<!doctype html>
<html lang="en">

<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">

  <link
    crossorigin="anonymous"
    href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap/5.1.3/css/bootstrap.min.css"
    integrity="sha512-GQGU0fMMi238uA+a/bdWJfpUGKUkBdgfFdgBm72SUQ6BeyWjoY/ton0tEjH+OSH9iP4Dfh+7HM0I9f5eR0L/4w=="
    referrerpolicy="no-referrer"
    rel="stylesheet"
  />
  <link rel="stylesheet" href="./static/css/oxford.css">
  <link rel="stylesheet" href="./static/css/outliers.css">

  <title>Static outliers for NHS Sheffield CCG</title>
</head>
<body>
    <div class="bg-dark">
      <div class="container d-flex justify-content-center">
        <a class="visually-hidden-focusable text-white p-2" href="#content">Skip to main content</a>
      </div>
    </div>

    <header>
      <nav class="navbar navbar-expand-lg navbar-dark bg-dark bg-oxford">
        <div class="container">
          <a class="navbar-brand" href="../index.html">OpenPrescribing outlier detection</a>
        </div>
      </nav>
    </header>

    <main id="content">
      <div class="bg-oxford-50 mb-4">
        <div class="container pt-5 pb-4">
          <div class="row">
            <div class="col-12">
              <h1 class="display-5 fw-bold lh-1">Static outliers for NHS Sheffield CCG</h1>
            </div>
            <div class="col-lg-8 col-md-9 col-12 pt-4 fs-5">
              <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
                explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to identify unusual prescribing and collect feedback on this prescribing to inform development of new tools to support
                prescribers and organisations to audit and review prescribing.</p>
              <p>This report has been developed to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. We calculate the number of prescriptions for each chemical
                  in the <a href="https://www.thedatalab.org/blog/161/prescribing-data-bnf-codes">BNF coding system</a> using the BNF subparagraph as a denominator, for prescriptions dispensed between April 2021 and August 2021. We then calculate the
                  mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs/STPs. From this we can calculate the “z-score”, which is a measure of how many standard deviations a given practice/CCG/PCN/STP is from the
                  population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier for prescribing lower than its peers.
              </p>
              <p>It is important to remember that this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where
                  it might not. Our full analytical method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a>.
              </p>
              <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=ccg+03N">survey</a>            or emailing us at <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can
                  send short or detailed feedback.
              </p>
            </div>
          </div>
        </div>
      </div>
    </main>

    <section aria-labelledby="higherHeading">
      <div class="container">
        <h2 class="pb-3" id="higherHeading">Prescribing where NHS Sheffield CCG is higher than most</h2>
      </div>
      <div class="container px-lg-4 mb-4">
        <div class="table-responsive">
          <table border="1" class="dataframe table table table-sm table-bordered" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Standard Deviation">std</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=1404000AA&amp;denomIds=14.4&amp;selectedTab=summary">Tick-borne encephalitis vaccine</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_0_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>2</td>
      <td>Vaccines and antisera</td>
      <td>5749</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>8.88</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_Gl1qcFqiVeriUGu1QFobVwRbiFibYmFM"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_Gl1qcFqiVeriUGu1QFobVwRbiFibYmFM" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=1404000AAAAABAB&amp;denomIds=14.4&amp;selectedTab=summary" target="_blank">Tick-borne encephalitis vaccine (inactivated) inj 0.5ml pfs : 2</a></li></ul></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0503010AT&amp;denomIds=5.3.1&amp;selectedTab=summary">Doravirine</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_1_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>2</td>
      <td>HIV infection</td>
      <td>16</td>
      <td>0.12</td>
      <td>0.00</td>
      <td>0.01</td>
      <td>8.37</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_bCupujEUGMLUVRu1raHGSIUSWkQxxOqe"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_bCupujEUGMLUVRu1raHGSIUSWkQxxOqe" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAg0AAACWCAYAAABdJrs9AAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAXEQAAFxEByibzPwAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAANqElEQVR4nO3de6xlZX2H8edlbtCBwVZtqEXYmJRLpxmBFAtWSkttAl2pLWUykGK4CVJrbCupujEUGMLUVRu1raHGSIUSWkQxxOqeEodysWUazAQBB+QygwsZBKo1QIeOwzDz9o/1zmHPmdsa9uXdl+eTrOz9rrXOOb/1nnX2/p53r0uIMSJJkrQ3++UuQJIkjQdDgyRJasTQIEmSGjE0SJKkRgwNkiSpEUODJElqxNAgSZIaMTRIkqRGDA2SJKkRQ4MkSWrE0CBJkhoxNEiSpEYMDZIkqRFDgyRJasTQIEmSGjE0SJKkRgwNkiSpEUODJElqxNAgSZIaMTRIkqRGDA2SJKkRQ4MkSWrE0CBJ0p6EsJAQYpoW5i4nJ0ODJElqZG7uArZrtTsfBTak6fGqLJ7LXJIkSeoSYoy5awCg1e50F7INWA6sqMpia6aSJEkifSSxMbUOJMaXc5aT0yh9PPFnwCeBm4FN1KFhVavdeUvWqiRJEjBCIw3dWu3OUcAtwNuBHwPnVmXxb3mrkiRNJUcaZozSSMOMqiweA04ErgXeBKxstTsfzluVJEnTbSRHGrq12p0zgJuA/YHTqrJYlbkkSdI0caRhxkiONHSryuI24H3Utd7cancOy1ySJElTaeRDA0BVFl8C/g54I3Brq91ZkLkkSZKmzliEhuQjwL3ACdQBQpIkDdHYhIaqLLYAy4DngUta7c75eSuSJGm6jE1oAKjK4ofAWcBW4HOtdueIzCVJkjQ1xio0AFRlcQ+wgvpsik9lLkeSpKkxdqEhKYGngDNa7c7v5C5GkqRpMJahoSqLTcClqfn3rXZnfs56JEmaBmMZGpLbgDuAo4EPZa5FkqSJN/JXhNyTVrtzDPAQ9Q2ujqrK4tnMJUmSJo1XhJwxziMNVGXxPeCzwEHUxzlIkqQBGevQkCynvnbDua1256TcxUiSNKnGPjRUZfEicFlqfqLV7oSc9UiSNKnGPjQkNwKPAqcAp2auRZKkiTQRoaEqi63Alal5jaMNkiT130SEhuRW6jMpTgROz1yLJEkTZ2JCQ1UW24ArUtPRBkmS+mxiQkPyr8Aa4DjgjMy1SJI0USYqNFRlEYHLU/PqVrszJ2c9kiRNkokKDck3gXuBxcCyzLVIkjQxJi40zBptuMrRBkmS+mPiQgNAVRZ3A3cBRwJn5a1GkqTJMJGhIbk6PV7uaIMkSb2b2NCQRhu+BRwDnJm3GkmSxt/EhoZk+2jDFa12Z9K3VZKkgZr0N9I7gdXUZ1J43QZJknow0aEhnUmxPDUdbZAkqQfT8Ca6CrgPWAK8J3MtkiSNrYkPDbsYbfCeFJIkvQ4THxqS23ntnhS/l7kWSZLG0lSEhjTacFVqLvfYBkmS9t00vXmupD624Vg8k0KSpH02NaEhjTZckZrLvUqkJEn7ZmpCQ7IK+E+8A6YkSftsqkJDGm34y9S8qtXuzM1ZjyRJ42SqQgPM3JPiTuo7YJ6TtxpJksbH1IWGZPtowxWtdmde1kokSRoTUxkaqrJYTX3thrcB5+etRpKk8TCVoSHpPrZhYdZKJEkaA1MbGqqyWAPcArwF+EjmciRJGnlTGxqSjwGbgY+22p1DcxcjSdIom+rQUJXFU8CngQOAFZnLkSRppE11aEhK4L+Bc1vtzq/mLkaSpFE19aGhKouXgMtT89PeOluSpF2b+tCQfBH4LnAy8IeZa5EkaSQZGoCqLLYCl6bm37Tanf1z1iNJ0igyNCRVWdwBfB04ArgyczmSJI0cQ8OOPgj8L/UpmCfkLkaSpFFiaOhSlcXTwF9Q98v1rXZnQeaSJEkaGYaGnX0B+HdgMa+dVSFJ0tQLMcbcNYycVrvTAtYC+wPvqMri/rwVSZKyCWEhsDG1DiTGl3OWk5MjDbtQlUVFfYnpOdQfU8zPW5EkSfkZGnbvc8A9wBLg6sy1SJKUnaFhN6qy2AZcCLwIfKzV7pyVuSRJkrIyNOxBVRZPAmcD26g/pjguc0mSJGVjaNiLqixupz6+4QDga6125+czlyRJUhaGhmY+BdwEvBX4qgdGSpKmkaGhgaosIvB+YA3wLuBa74YpSZo2hoaGqrLYBPwB8BxwEfD5VrszJ29VkiQNj6FhH1Rl8QzwbuBZ4GLgxla7My9vVZIkDYehYR9VZfEwcDLwFPBHwFe8lbYkaRoYGl6HqizWUx/b8Bjw+8A3Wu3OorxVSZI0WIaG16kqiw3AbwAPAr8NPNhqd96VtypJkgbHG1b1qNXuvIH6zphLgQj8NXBlVRavZC1MktQf3rBqhiMNParK4gVgGXAe9U7VBu5rtTtLshYmSVKfOdLQR+mW2jdSHygJcCtwTVUWD2YrSpLUG0caZhga+ixdu+FPgI8Dh6TZXwNWAGvShaIkSePC0DDD0DAgrXbnAOB91B9X/GKa/SjwlTStNUBI0hgwNMwwNAxYq91ZAFwA/DHw9q5FjwF3APcB3waeSLfjliSNEkPDDEPDELXanV+iPstiKXD8rMUvAA8A64Enge+n6Xngx8BGRyYkadfSR8PzdzHN2838puvs93P/9+K8+z97zmUAx3/opmt+8jNv2EJ9ttz26VVgC/DKPjx2T5tnt6uy2Nr/XuqdoSGTVrtzOHAS8A7g16hDxJ6uLLmZOjy8BGxK00+7nne3twDbqHfmbXuZYtfjsHeGSf95e9Pkpmf9WmfYP8+arGn7OnP3cZqzi3m7e1Pvnj+wswEPeOWnfO8zSwE45sO3smn+UC4CvI09hIo9tLcA26qyOGcQRc0dxDfV3lVl8RT1pai/BJDuYfG2NB2RHlvAm4E3pekQXjs+QpKm1RZe+4/9JXb+z737DXR3y5ou37po88YFwOcBFm1++QOb5u+/hToQbZ+2j3J0h5h5e3nc3bRgF+0D0/N9uUniQELDSIw0hBAeBogxLs5dyyiwP3Zmn+zI/tiR/bEj+2NH9kf/eHEnSZLUiKFBkiQ1YmiQJEmNGBokSVIjhgZJktSIoUGSJDUyEqdcSpKk0edIgyRJasTQIEmSGjE0SJKkRgwNkiSpEUODJElqxNAgSZIaGUpoCCH8Zgjh4RDCuhDCdSGEnW7vGUJYFkJ4PISwPoSwomv+ohDC10MIT4QQ1oQQjhlGzYPUY398MoTwaAjhwRDCqhDC4cOtvv966Y+u5SeGELaGEN47nKoHp9f+CCFcEEJ4JISwNoTwzeFVPhg9/r0cEUK4K4TwnfQ9Lhpu9f3XsD++HEL4UQhh3az5c0MI16evfTiEcPLwKh+MHvvj0vS1D4UQ7g0hHDu8ysdUjHGgE3UwWQf8cmp/GThv1joHAz8AfgGYC6wGTknLrgH+Kj3/XeCuQdc84v1xGjAvPf8AcFvubcrZH2n5fOBbQAd4b+5tyrx/nAT8F7AotQ/JvU2Z++Ofgfen528GXgAOyr1dg+yPNP9U4Hhg3az5FwH/kp4vAR4nXa9nHKc+9MepwML0/HTgO7m3adSnYYw0nAD8MMb4SGr/I3DmrHVOA+6OMT4bY3wV+Keudc4ErgOIMa4EjgwhvHHwZQ9MT/0RY7w9xrglrXcfcNgQah6kXvcPgI8DNwA/GnCtw9Brf/wpUMYYXwKIMT43hJoHqR/7x8Hp8UDgReCVAdY7aE36gxjjncBPdvH13a+nDwH/Axw3mFKHoqf+iDHeGWN8OTUn4fV04IYRGg4Fnu5q/wB46z6sM3vZhjRvXPXaH90uAVb2tbrh66k/QgiLgXcC1w+wxmHqdf84Gjg+hLA6hPDtEMLSgVU6HL32x2XA+SGEDcBa4IMxxs0DqnUYmr42DOrrR00/t2cSXk8Hbu4Qfkbo0zqToi/9EUK4mPo/hFN6riiv190fIYT9gH8ALokxxhAmYjfqdf+YCxwOnAwcAqwOIdwfY3yyH8Vl0Gt/nA3cEmO8OoTwK8DKEMLdMcaN/Slv6HrdySfij6RLX7YnhHA6cAHw6/34fpNsGCMNT7Nj8juMerSg6TobZi07FHimzzUOU6/9QQjhTODPgSLGuGlAdQ5LL/1xELAYuD2EUAFLgc+EEC4cWLWD1+v+8TTw1Rjj1hjjM9RDrksGVOsw9Nof5wE3A8QY1wLPAUcOpNLhaNIfg/z6UdPz9oQQ3glcS/16OgkfcQ7WoA+aAOYAT7LjgSoXzFrnYOpffveBTL+Vlq1gxwMh78l9IEjm/ng38ARwWO5tGYX+mLXeDYz/gZC97h8XAn/btd564Kjc25WxP1ZSfyQB9ZvL88DP5t6uQfZH17otdj7w72J2PBByHeN9IGSv/bEE+D5wbO5tGZdpWL/YU4FH0gvYF9Mf9nuA67rWOTu9Ga4HPtE1/2DgG2nZ/cDi3J2WuT+eoB5peSBNd+Tenpz9Mev73MCYh4Y+7B9zgS8AD1N/hn9x7u3J3B9HA/8BPAR8F1iWe3uG1B8d4FngVer/vC9L8+dRHyi6Ln2PU3JvT+b+WEV9APUDXdP83Ns0ypO3xpYkSY14RUhJktSIoUGSJDViaJAkSY0YGiRJUiOGBkmS1IihQZIkNWJokCRJjRgaJElSI4YGSZLUiKFBkiQ1YmiQJEmNGBokSVIjhgZJktSIoUGSJDViaJAkSY0YGiRJUiOGBkmS1IihQZIkNWJokCRJjRgaJElSI4YGSZLUiKFBkiQ1YmiQJEmNGBokSVIj/w/sYegM7+GTKgAAAABJRU5ErkJggg=="></div></div></div></div></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0503010ATAAAAAA&amp;denomIds=5.3.1&amp;selectedTab=summary" target="_blank">Doravirine 100mg tablets : 2</a></li></ul></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=1203030N0&amp;denomIds=12.3.3&amp;selectedTab=summary">Menthol</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_2_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>5</td>
      <td>Lozenges and sprays</td>
      <td>19</td>
      <td>0.26</td>
      <td>0.01</td>
      <td>0.03</td>
      <td>8.00</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_gBbbzthtaSVWwbXjaGuHmSIHDG0KBSc"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_gBbbzthtaSVWwbXjaGuHmSIHDG0KBSc" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=1203030N0BIABA0&amp;denomIds=12.3.3&amp;selectedTab=summary" target="_blank">Vocalzone Throat pastilles original : 5</a></li></ul></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0408020D0&amp;denomIds=4.8.2&amp;selectedTab=summary">Clonazepam</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_3_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>9</td>
      <td>Drugs used in status epilepticus</td>
      <td>445</td>
      <td>0.02</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>6.35</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_MChil5rEUpFWSwmICSlA0QgY1KjRJpTg"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_MChil5rEUpFWSwmICSlA0QgY1KjRJpTg" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAg0AAACWCAYAAABdJrs9AAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAXEQAAFxEByibzPwAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAQOklEQVR4nO3dfZAkdX3H8fcPluPkToT4EEWEURMUTikSNTEaRCUqoWM08SFGLz5FyopJMChil5rEUpFWSwmICSlA0QgY1KjRJpTgA/gQUz4dyoFygA0HaiWKEbkcHNz98sf81pubu9nt3Z3e7pl9v6q6pp/n+9vf9M5ne3qnQ4wRSZKk+ezVdgGSJGkyGBokSVIthgZJklSLoUGSJNViaJAkSbUYGiRJUi2GBkmSVIuhQZIk1WJokCRJtRgaJElSLYYGSZJUi6FBkiTVYmiQJEm1GBokSVIthgZJklSLoUGSJNViaJAkSbUYGiRJUi2GBkmSVIuhQZIk1WJokCRJtRgaJElSLYYGSZIGhbCGEGIa1rRdTpcYGiRJUi0zbRdQRy8vXw9sTMNNVZHtaLkkSZJWnBBjbLuGefXycrDILcAG4A1VkV3ZUkmSpGnV/0jijjS1lhi3tFlOl0zKxxOvAc4DvgbsAJ4IXNHLyzN6eennTZIkLYOJONMwqJeXAXgh8F7gQOAG4OWedZAkjYVnGkaauNAwq5eXDwTOBp6VZp0JnFwV2d3tVSVJmniGhpEm5eOJ3VRF9mPgj4D1wM+AE4Fze3k5sW2SJKnLJvoNtiqyWBXZBcBRwC3Ai4F3tFuVJEnTaaJDw6yqyG4Gng7cBpzcy8uTWy5JkqSpMxWhAaAqsmuBDNgKvKuXly9uuSRJkqbK1IQGgKrIvgY8F9gOvL+Xl8e3XJIkSVNjqkIDQFVklwAvA/YGPtbLy3UtlyRJ0lSYutAAUBXZvwBvAu4FfLiXl6taLkmSpIk3laEhKYAr6f9nxVtarkWSpIk3sV/uVEcvLw8FvgPcG3hKVWRXtFySJKnr/HKnkab5TANVkd0EvAoIwId6eXmflkuSJGliTXVoSC4EPgIcApzVci2SJE2sqQ8NVZFF+mcbbgHW9/LyBS2XJEnSRJr60ABQFdnPgJekyX9KN7uSJEkLsCJCA0BVZJ+nfyfMA4B3t1yOJEkTZ8WEhuRNwA+BF/by8ti2i5EkaZKsqNBQFdkvgFenyX/s5eW+bdYjSdIkWVGhIfk4cClwGHBKy7VIkjQxpvrLnUbp5eXDgavpf3/DuqrIbmi5JElSV/jlTiOtxDMNpJBwKrAvcFYvL0PLJUmS1HkrMjQk7wK+DxxH/3bakiRpDis2NFRFdhf9L30C+IdeXt67zXokSeq6FRsa4Jff3XAhcBDwty2XI0lSp63o0JC8jv4FLyf18vLwtouRJKmrVnxoqIrsh8CbgRngvV4UKUnSnq340JCcCVwDHIsXRUqStEeGBqAqsruBv06T7+nl5do265EkqYsMDUm6KPJi4GDgDS2XI0lS5xgadvVaYAtwci8vD2u7GEmSusTQMKAqsluAtwL7AGd6UaQkSTsZGnZ3OnAd8Azg2S3XIklSZxgahlRFto2dF0We3svL/dqsR5KkrjA07EFVZJ8F/g04FMhbLkeSpE4wNIx2ErAVOCXdSluSpBXN0DBCVWQ3s/P22We0XI4kSa0zNMzt3cANQNbLy2e2XYwkSW0yNMyhKrI7gRPT5Bm9vFzdZj2SJLXJ0DCPqsguAf4deChwSsvlSJLUGkNDPScBdwJv9PbZkqSVytBQQ1VkNwJ/D6wC3t/Ly71bLkmSpGVnaKjvPcDXgccDr265FkmSll2IMbZdw8To5eWjgG8B24EjqyLb1HJJkqRxC2ENcEeaWkuMW9osp0s807AAVZFdDbwFWA2c18tLf36SpBXDN72FewewATgaeFXLtUiStGz8eGIRenl5FP3rG+4CHl0V2Q9aLkmSNC5+PDGSZxoWoSqyDUABrAE+0MvLmZZLkiSpcYaGxXsbcBVwDP1/x5Qkaar58cQS9PLy14FvAmuB49IttSVJk8yPJ0byTMMSpH+5fAUQgAt6efnglkuSJKkxhoYlqorsYuB9wP2Aj3h9gyRpWhkaxuO19D+m+F361zpIkjR1DA1jUBXZXcDzgJ8Dr+/l5R+0XJIkSWNnaBiT9F0NL0mTF/Xy8rFt1iNJ0rgZGsaoKrJPAW+k/98Ul6T/rpAkaSoYGsbvNOBM4P7AZ3t5eVDL9UiSNBaGhjGriiwCJwEfAXrAf/Ty8oBWi5IkaQwMDQ2oimwH/esbLgeOBD7Vy8t7tVuVJElLY2hoSFVk24A/Br4BPIl+cNi/3aokSVo8Q0ODqiL7BXA88F3gacCX/NZISdKkMjQ0rCqy/wGOBj5H/6OKr/Xy8tHtViVJ0sIZGpZBVWQ/p3/G4YPAwcCXe3l5bLtVSZK0MN7lchn18jIAbwb+DriH/tdPn5UunJQkdYF3uRzJ0NCCXl6+HPhnYAb4IvDnVZHd2GpRkqQ+Q8NIhoaW9PLyKPofVxwJbAFOAc72rIMktczQMJLXNLSkKrINwOOAtwKr6d9e+/JeXh7RamGSJI3gmYYO6OXlY4DzgUcBEfgo8LaqyL7bZl2StCJ5pmEkQ0NH9PJyX+Av6X9M8atp9seBt1ZFdlVrhUnSSmNoGMnQ0DG9vNwPOAF4PfCgNPs/gQuBi6si+++2apOkFcHQMJKhoaN6ebkaeAX9m189LM3eDlwGXARcVhXZj1oqT5Kml6FhJENDx6Xvdvgt4EXAnwAPGFi8CbgiDV8Gbkp32ZQkLZahYSRDwwTp5eUM8FT6N8J6EnD40Cq3A9cAG9NwLXAzsDndB0OSNB9Dw0iGhgnWy8sH0A8PxwCPB44A9hux+s/pB4hbgZ8MDT+j/10Rd6Rhy+BjVWR3N9cKDUpnlvYeGGaGpvc0b4Zd/306poGhx7nG75lj2A7c41ksTYJeXu7FzuNidljQ9ENvu3XtF855ZQlw9CvPfd7mAx64Pa0DEBb4uJhtBreF/jG6g53H63zjO6oi+9RuP5wxMDRMkXSwHAqsS8NhwEPScAijA8V8ttEPEFuBu4eGbfNMz87bwcALeg+Pcy3b02OYY2Ce5XW23Yvdf5ksdrzO8tmhy9+dsoN5gsU8w/A629nZ9zv2ML3UebOvlUFdn4bxvNmM841rrn3NvkHPF2znG+ZbfyEBYPgNd8Hute1Orj39uQAcftLH2Lpq9VJ3ueyqIlvyz2FPZprYqdqRvk3yB2n4zOCy9BfsgcBBwH2B+w08HgisAdYOPA6PrwX2Z2fa1uIMvmFuB+4aGN8+tGwh08NhiqHHUeOw8xf/zDzD8Dqr6AfR2WlpOcyGxMEAeuce5o0KqvOus2r73QDrAfbdvu3srayePU73dAavzuNitpl9HPyjZq8FjDei82caQggbAWKM69quZammqS0wXe2ZprbAdLXHtnTXNLVnmtrSpC6fCpUkSR1iaJAkSbUYGiRJUi2GBkmSVIuhQZIk1WJokCRJtXT+Xy4lSVI3eKZBkiTVYmiQJEm1GBokSVIthgZJklSLoUGSJNViaJAkSbUsS2gIITw5hLAxhHB9COHcEMJut1cOITw/hHBdCOGGEMKpA/P3DyF8OoSwKYTwjRDC4UvZpottCSEcFUL4Strv1SGEEwe2eWkI4achhA1peF+X25KWxYF6N4QQ7pvmz4QQPpCeb2MI4ehxtaWp9qS+GWzLbSGE09OyrvbN76d67gkhrK+z3yb7pom2hBAeEkL4XAjh2rTv04ae7xcD/fKJcbWlqfakZVXa72zdjx5YVqTnuy6E8JwutyWE8IChY+bHs33Q8b55ZwjheyGEq0IIl4UQDp1vv00eN50VY2x0oB9MrgeOSNMXAy8ZWuc+wM3Ag4AZ4KvAMWnZ24C3p/HjgS8sdpsOt+Uw4BFpfH9gE3BUmn4pcO6k9EuavmfEc74CuDCNHwlcR/qukC63Z2gfm4AndLxvfg14FPAhYH2d/TbVNw225UHAY9P4KuBLwLPS9JOBy8fdL022Jy2rgIP38Jy/B1wJ7A08OO17bZfbMrSPy4EXTkDfHAfsk8b/AvhEW8dNl4flONPwOOCHMcZr0vR5wHBSPg74YozxRzHGe4APDqzzHOBcgBjjJcBhof+X62K26WRbYozXxRi/n+bfDlwLPGQM9c6lqX6Zy+A23wF+CvzGUhuSNN6eEMJv0/+F8NUx1TzKktoSY7w+xng1sGMB+22qbxppS1r3G2l8G/Bt4JAx1DufpvpmLs8Bzo8xbo8x3gp8BXj6UhqRNN6WEMJBwGOBT46h3vkstT2XxhjvTuv9FztfT20cN521HKHhYGDzwPTN7P6GONc6w8tuSfMWs81SNdWWXwohPJz+QfaVgdnPTKfMPhtCeNziy69dZ5115mrLXiGEr4cQvhlCeM0Cn3OxGu8bYD3w4aF5Xeybxey3qb5pqi2/FEL4FeDZwGUDsx8TQvh2COHKEMIzFlbynJpuz6fTaftTQwj7jGF/c2m8b4A/BT4ZY/y/gXmT0DevBC6psU2Tv9M6aWYZniOMaZ1xbLNUTbWlv2EIB9BP5K+OMd6WZn8G+NcY49YQwjHAJ0IIj4wx3rHY51lAnYtty6Exxs3pL/VPhhB+FGO8aAn7q6PpvpkBng88cWD2pPXNXNs01TdN98sq4GPAGTHG76XZ36L/Grw9hLAOuDSE8KQY4w8W+zwLrHWx7Tk6HTdr6P8FfDJw2hL2N59G+yZZD7xuYLrzfRNCOIH+2YJjamzTxvtQq5bjTMNmdk1eh9D/K67uOrcMLTsYuHWR2yxVU20hhLAfUALnxBg/OrtCjPEnMcatafyKtI9HLLklDbYlxrg5Pf4UuAB4wgKec7Eaa0/yDODGGOP1szM63DeL2W9TfdNUW0gXo10IbIgxvnt2fozx9vQxHzHGjfTP2v3moqrfXWPtGThuttA/5d30cdNYWwBCCEcA9wc+Pzuv632TLjL9GyCbPbbn2abJ32nd1PRFE/Qv3rmRXS8iednQOveh/8MfvDjlKWnZqex6gdoVi92mw23ZB7gUePMenvOggfF1wI+BAzvclgOB1Wl8Nf1TfCek6RPY9aKh6xnfhZCNtGdg24uAV01C3wyscz67Xjw4cr9N9U1TbUnzzgM+MFxn2s/szfgeDNwEPLILr7M5+mYNsP/Ac5wDnJqmn8auF0JuBu7d1bYMzD8NeOek9A39C043AYfU3W9Tx02Xh+V5EngqcA1wA/D+1Fl/yMCV58ALUofdAJw21MmfScu+BaxbyjZdbAvwImA7sGFgeG5a9nZgY5r3deC4jrfld4DvAlelut8B7JWW7UP/tOv16XmPmZDX2Vrgf4H7Dj1fV/vmWPp/7WwBbkvj+47ab9N900Rb6H9MFNNrbfaYOTFt81cD/bIB+LMOvc5GtedhqdbvpNrPBfYb2O6daV+bgOd1uS1pWaAfCI4cer4u980m+mcXZ2u7fK79Nn3cdHXw1tiSJKkWvxFSkiTVYmiQJEm1GBokSVIthgZJklSLoUGSJNViaJAkSbUYGiRJUi2GBkmSVIuhQZIk1WJokCRJtRgaJElSLYYGSZJUi6FBkiTVYmiQJEm1GBokSVIthgZJklSLoUGSJNViaJAkSbUYGiRJUi2GBkmSVIuhQZIk1WJokCRJtRgaJElSLYYGSZJUy/8Dlyb0CZJTMVkAAAAASUVORK5CYII="></div></div></div></div></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0408020D0AAAAAA&amp;denomIds=4.8.2&amp;selectedTab=summary" target="_blank">Clonazepam 1mg/1ml inj ampoules and diluent : 9</a></li></ul></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0603020H0&amp;denomIds=6.3.2&amp;selectedTab=summary">Dexamethasone sodium phosphate</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_4_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>23</td>
      <td>Use of corticosteroids</td>
      <td>27941</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>5.98</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_DaiYI3bBVPSUFCGxpVXWLgZqtELgDIIW"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_DaiYI3bBVPSUFCGxpVXWLgZqtELgDIIW" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0603020H0AAALAL&amp;denomIds=6.3.2&amp;selectedTab=summary" target="_blank">Dexamethasone (base) 3.8mg/1ml solution for injection vials : 23</a></li></ul></td></tr></tbody></table>
        </div>
      </div>
    </section>

    <section aria-labelledby="lowerHeading">
      <div class="container">
        <h2 class="pb-3" id="lowerHeading">Prescribing where NHS Sheffield CCG is lower than most</h2>
      </div>
      <div class="container px-lg-4 mb-4">
        <div class="table-responsive">
          <table border="1" class="dataframe table table table-sm table-bordered" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Standard Deviation">std</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0902013S0&amp;denomIds=9.2.1&amp;selectedTab=summary">Sodium bicarbonate</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_0_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>1201</td>
      <td>Oral bicarbonate</td>
      <td>1205</td>
      <td>1.00</td>
      <td>1.00</td>
      <td>0.00</td>
      <td>-4.23</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_qfg0T5VCLZdSaUsbUiFaSqsPCvEPjg8q"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_qfg0T5VCLZdSaUsbUiFaSqsPCvEPjg8q" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0902013S0AAACAC&amp;denomIds=9.2.1&amp;selectedTab=summary" target="_blank">Sodium bicarbonate 500mg capsules : 1199</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0902013S0AAAQAQ&amp;denomIds=9.2.1&amp;selectedTab=summary" target="_blank">Sodium bicarbonate 500mg gastro-resistant capsules : 2</a></li></ul></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0601011A0&amp;denomIds=6.1.1&amp;selectedTab=summary">Insulin aspart</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_1_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>4675</td>
      <td>Short-acting insulins</td>
      <td>9427</td>
      <td>0.50</td>
      <td>0.78</td>
      <td>0.08</td>
      <td>-3.44</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_lOYYk6ixjImIBlcwLhBACNGj5YKoMREU"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_lOYYk6ixjImIBlcwLhBACNGj5YKoMREU" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0601011A0AAABAB&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">Insulin aspart 100units/ml inj 3ml cartridges : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0601011A0AAACAC&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">Insulin aspart 100units/ml inj 3ml pf dispos dev : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0601011A0BBAAAA&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">NovoRapid 100units/ml solution for injection 10ml vials : 430</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0601011A0BBABAB&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">NovoRapid Penfill 100units/ml inj 3ml cartridges : 2575</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0601011A0BBADAC&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">NovoRapid FlexPen 100units/ml inj 3ml pre-filled pens : 1160</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0601011A0BBAEAC&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">NovoRapid FlexTouch 100units/ml inj 3ml pre-filled pens : 48</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0601011A0BBAFAD&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">NovoRapid PumpCart 100units/ml inj 1.6ml cartridges : 65</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0601011A0BCAAAC&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">Fiasp FlexTouch 100units/ml inj 3ml pre-filled pens : 107</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0601011A0BCABAB&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">Fiasp Penfill 100units/ml inj 3ml cartridges : 238</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0601011A0BCACAA&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">Fiasp 100units/ml solution for injection 10ml vials : 45</a></li></ul></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0407020Q0&amp;denomIds=4.7.2&amp;selectedTab=summary">Morphine sulfate</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_2_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>12213</td>
      <td>Opioid analgesics</td>
      <td>98167</td>
      <td>0.12</td>
      <td>0.22</td>
      <td>0.04</td>
      <td>-2.63</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_gIoKsi2ox0XxgSiLCHsEDcihBJFVUFBQ"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_gIoKsi2ox0XxgSiLCHsEDcihBJFVUFBQ" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0407020Q0AAA6A6&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine sulfate 20mg/ml oral solution sugar free : 9</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0407020Q0AAABAB&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine sulfate 10mg/1ml solution for injection ampoules : 548</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0407020Q0AAADAD&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine sulfate 30mg/1ml solution for injection ampoules : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0407020Q0AAAHAH&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 100mg modified-release tablets : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0407020Q0AAAIAI&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 60mg modified-release tablets : 22</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0407020Q0AAAKAK&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 10mg modified-release tablets : 251</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0407020Q0AAALAL&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 30mg modified-release tablets : 107</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0407020Q0AACDCD&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 10mg tablets : 121</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0407020Q0AACECE&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 20mg tablets : 29</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0407020Q0AACFCF&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 15mg modified-release tablets : 29</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0407020Q0AACGCG&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 5mg modified-release tablets : 150</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0407020Q0AACNCN&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine sulfate 10mg/5ml oral solution : 2496</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0407020Q0AADRDR&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 50mg tablets : 10</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0407020Q0AAEFEF&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 10mg modified-release capsules : 164</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0407020Q0AAEGEG&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 30mg modified-release capsules : 65</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0407020Q0AAEHEH&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 60mg modified-release capsules : 8</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0407020Q0AAFXFX&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 0.1% in Intrasite gel : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0407020Q0AAGAGA&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine sulfate 10mg/10ml solution for injection ampoules : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0407020Q0BBAAAK&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MST Continus 10mg tablets : 367</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0407020Q0BBABAL&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MST Continus 30mg tablets : 182</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0407020Q0BBACAI&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MST Continus 60mg tablets : 102</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0407020Q0BBADAH&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MST Continus 100mg tablets : 17</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0407020Q0BBAGCP&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MST Continus suspension 30mg granules sachets : 12</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0407020Q0BBAKCG&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MST Continus 5mg tablets : 374</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0407020Q0BBALCF&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MST Continus 15mg tablets : 168</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0407020Q0BCAGCN&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Oramorph 10mg/5ml oral solution : 3322</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0407020Q0BHACCD&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Sevredol 10mg tablets : 28</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0407020Q0BHADCE&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Sevredol 20mg tablets : 9</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0407020Q0BKAAEF&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Zomorph 10mg modified-release capsules : 2106</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0407020Q0BKABEG&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Zomorph 30mg modified-release capsules : 1174</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0407020Q0BKACEH&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Zomorph 60mg modified-release capsules : 228</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0407020Q0BKADEB&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Zomorph 100mg modified-release capsules : 60</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0407020Q0BNAAAK&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphgesic SR 10mg tablets : 21</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0407020Q0BNABAL&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphgesic SR 30mg tablets : 9</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0407020Q0BNACAI&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphgesic SR 60mg tablets : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0407020Q0BNADAH&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphgesic SR 100mg tablets : 9</a></li></ul></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0403040W0&amp;denomIds=4.3.4&amp;selectedTab=summary">Venlafaxine</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_3_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>13500</td>
      <td>Other antidepressant drugs</td>
      <td>92393</td>
      <td>0.15</td>
      <td>0.26</td>
      <td>0.05</td>
      <td>-2.27</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_MRIQIwkguKCoBHApVAgYUDDs67ANYLGj"><img width="250" class="h-auto" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAg0AAACWCAYAAABdJrs9AAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAXEQAAFxEByibzPwAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAUaklEQVR4nO3deZQlVWHH8e9lh2HfV1OyyA6DgAs7HBGxAI0gkRgNCDEaEfSIx8K4ouIzMRIQIwkguKCoBHApVAgYUDDs67ANYLGjwLAvMzBT+ePeZ/f09DDV9FLd730/59zzuuvVgzt9u/r93q27hLqukSRJWpTF2q6AJEmaGgwNkiSpEUODJElqxNAgSZIaMTRIkqRGDA2SJKkRQ4MkSWrE0CBJkhoxNEiSpEYMDZIkqRFDgyRJasTQIEmSGjE0SJKkRgwNkiSpEUODJElqxNAgSZIaMTRIkqRGDA2SJKkRQ4MkSWrE0CBJkhoxNEiSpEYMDZIkqZHeCA0hTCOEOpVpbVdHkqRe1BuhQZIkjbsl2q6ApNHLinJpYC1gFWDlQWUlYEVg6WHKYsA8oE6P3fIC8PyQ8gwwa0h5surk8ybkHyhpUgh1Xbddh9GLtySeTd8tT10/12Z1pLGUFeViwDrAhsBGqbwmHeuW1Vqo2jzgUeBB4KFUHkzlnlQeqDr53BbqJmkcGBqkSSIrysWJwWBrYKtUtiCGhGVe4aUvAg+n8jjw5JDyTDpndipz0uM8IBB7HLqPiwPLAssNKSsSezFWA1ZNZTVi78aSr1C3OUBFDBB3ArcAM4AZVSd/atE/FUmTiaFBakEKCJsCbwB2TI9bMXw4mAXcTXzjvTuVe4mf7B8Gnqo6eSsXcuoFWQ1YD1g3PW7AQK/IhsCaC3n5A8QQcR1wNXAN8GBb/xZJi2ZokCZAVpTTgDcDuwM7AzsAKww57QngZuIbabfMqDr5rAms6pjLinIFYnjYDNiSGI62BDZmwcHYjxDDw5XAZcBVVSd/ceJqK+mVGBqkcZAV5bLArsCexKCwI/MPPH4OuBa4alC5r58+ZWdFuQzx9sv2xJ/PDsRbM4N/TrMZCBCXAldUnfz5Ca6qpMTQII2BrCgDsAmwL/A2YA/mv9XwKPFN71LiG+AMBwguKIWtbRnoldmVOH6i60Xiz/BXqczsp6Altc3QIL1KWVEuAewG/DWQA68d9PRTwP+kcilwu29uI5fGTGxJ/DnvAexNnEbadQ8xPJwLXFZ18pcnuo5SPzE0SCOQPgm/lRgU9mf+T8HXAr9O5f98Axt7Kai9idijsy+w3aCnHwPOB84BLqk6+UsTX0OptxkapEVICyftAxwCHECcgghxOuHFwHnAL6pO/kg7NexfWVGuDewHHAi8hYHxEE8Q2+V7wO9chEoaG4YGaRhpSuQexKBwIHF1RYi/ZxcQ35AuqDr5061UUAvIinIVYqg7iNgbtFR6qiKGh+9Vnfzudmon9QZDgzRIVpSbAYcC7yOuOwCxR6EEfgSUjt6f/LKiXAl4N/B+4mDKrt8DpwI/cSqnNHKGBvW99AbzN8BhxPvlEPdjuBj4IXBe1cmfbKl6GqWsKDcihsD3MzBYdRZwBnBK1cnvaqtu0lRjaFBfSlMk3wR8iPiJdNn01EzgTGJX9gPt1E7jIbX57sCHgXcxMP7hQuBbxF4kp8FKr8DQoL6SFeWKwHuJYWGbdPhZ4MfET55XODWy92VFuQ5wOPCPwPrp8EzgBOC73oKShmdoUF/IinJr4EhiYJiWDl8PnAL8sOrkzy7stepdaQrnfsDRxIGvEDf9+jZwctXJ/9RS1aRJydCgnpVmQOwHHAXslQ6/AJxNDAtX26ugrqwotwc+ARxM3O1zDvFW1deqTn5Pi1WTJg1Dg3pOGtj4AWLPwobp8B+Bk4Ezqk7+RFt10+SXFeVriEHzg8RNxeYCZwFfrTr57W3WTWqboUE9IyvKDYCPAf/AwA6SlwAnAb90kJtGIivKlYnB8+PElT9r4KfA8VUnv7HNukltMTRoysuKclvgGOA9xBHxs4EfACdWnfzmNuumqS8ryuWJA2ePAdZKh88BPl918ltbq5jUAkODpqRB0+c+TdzECOLSwf8BfNMBbBprad+RI4CCuPDXPOJtiy845kH9wtCgKSWFhX2AzwA7p8MV8A3ieAVnQWhcpfDwT8TwsDrwMnA68GXX9lCvMzRoSkhh4QBiWNghHZ4BHE9cEtgdJTWhsqJcgThV8xjidt2ziVM1v1p18j+3WTdpvBgaNKmlaZMHAv/MwGJM1wNfBs5390K1LSvKVYnB4WjiDqjPAScCX3emjnqNoUGTUlp05xDimIXN0uErgS8Rd5fsgV9c9ZKsKNci3rL4MLA08BTwdeDfvW2mXmFo0KSSFeVSxI2FjmVgjYVLiT0LFxsWNNmlqb+fIa4VsgTwKPH39z+rTj67zbpJo2Vo0KSQbkMcAhzHwE6EFxIHl/2utYpJr1LaXfOLwN8CAbgX+ALwfdcM0VRlaFCr0gDH/YgDGrdKhy8Ajqs6+ZWtVUwaI2nfk68A+6dDtxHH6Jxvz5mmGkODWpMV5W7AV4Gd0qHLgaLq5L9vr1bS+MiKcifi7/tu6dBVwKerTn5xe7WSRsbQoAmXFeV0Ys/CvunQTcQBjw5wVE8btM7I8cB26fDFwLFVJ7+6tYpJDRkaNGGyotyYOPvhPenQPcBngbOdOql+khXlYsBBxAGSm6TD5wKfqTr5ba1VTFoEQ4PGXVaU6xLDwRHE0eSPEMPDaVUnn9Nm3aQ2ZUW5JHAo8HlgPeLS1N8lLk19X4tVk4ZlaNC4yYpyFeBTxG2GlyXOW/8acFLVyW0jKRm0NPWxwGrAHOLqkse7uqQmE0ODxlxWlMsRg8KngJWBF4kr5P1L1clntVk3aTLLinJF4BOpdP+unQB8o+rkT7ZZNwkMDRpDqav1COBzwNrAXOA04EtVJ3+wzbpJU0lWlGsSBwd/GFiK2Et3InF1SZemVmsMDRq1NKjrPcSFmTZKh88GPld18pmtVUya4rKi/Cvimg6HEccDPQOcBJxQdfLH26yb+pOhQa9amj62L3H62Lbp8K+Jc8+vb61iUo9J4aEADgeWJP69Oxk4serkj7RZN/UXQ4NelawodyEuVLNLOvQH4lzzS9urldTb0r4WBfE24FLE7bi/S9xR0149jTtDg0YkK8ptiEvi7pcO3ULsPv2FCzNJEyMryvWAjwEfApYHauC/ga9VnfyaNuum3mZoUCNZUW5IHLPQ3XynIg54/KGb70jtyIpyZeJgyaOBtdLhy4BvEve2eLmtuqk3GRr0irKiXJu4MNMHiQOx/kxcmOlUt/mVJoesKJcB/p44VbO7wuT9xLUeTq06+WNt1U29xdCgYaVPMJ8kdoEuBzwN/Ctxytezr/RaSe1IM5n2AT7KwN4us4EfAacCf/A2okbD0KD5pIWZjiQOtlqF+AfnZKDjpxVp6siK8nXEa/kw4rgHiNtynwZ8v+rkj7ZVN01dhgYBf1mY6TDiGvjrEtfA/w5wXNXJ72+zbpJevbTK5CHE6Zo7psMvAT8DzgQucg8YNWVo6HNZUS4OvJcYFjZMh38KfLbq5He0VjFJYy7NfjoceB+xJxFgFnAOcUG2yxzYrFdiaOhT6d7nwcAXgE3T4d8Qt+Z1ypbUw9LAyXcQZ0PtS1wwCuAh4CfAecDlBggNZWjoM2kVx3cCXwS2Tod/S+xZuLy1iklqRdqN9l3EALEncUo1wOPAL4m3MS50Z1qBoaFvDFry+UvA69PhK4hh4ZLWKiZp0siKch1igDiAGCC6PRCzgUuAC4GLgFudhdGfDA09LoWFvYAvA29Kh68hrr3wGy98ScPJinIl4G3E2xhvB1Ya9PRDxPBwEfC/7mLbPwwNPSqFhd2JYxZ2T4dvIq7i+HPDgqSm0uyqNwJvBfYG3gAsNuiUe4DfDSoz/RvTmwwNPSaFhbcR94PYOR2+nTg74pyqk89rq26SekMaB7En8BZgN2DLIaf8GbgqlSuBq6tO/sSEVlLjwtDQI9JsiHcSw0J3zMKtxG2rz3YUtKTxkhXlasQPKbumsj1x2fnBZgLXATemchPwoD0SU4uhYYrLinJp4qjnY4At0uFriTtR/syeBUkTLU3pnE68jdEtmwxz6izmDxE3EgdZvjhBVdUIGRqmqNQ9+CHgKGDtdPj3xLDgAEdJk0pWlKsC26ayTXrcElh6yKlzibdUbwZmEHtMbwXurjr5SxNWYQ3L0DDFpC2qjyau6jYNqIkLsfxb1cmvaLNukjQSWVEuQVxcrhsiumWdYU5/CbiDgRDRLTNdBnviGBqmgDReYW/i5jM5cfGVF4EzgBOqTj6zxepJ0pjKinINYi/EFql0v15zmNNfJo6X6IaIbu/EnVUnnz0hFe4jhoZJLM2TPhT4CAP3Ax8GTgG+7S51kvpJVpSrA5szf6DYguF7JuYCdzP/LY5bgTuqTv7ChFS4BxkaJpk0ZXIn4u2Hg4m3ICDOfT4ZOM/7epI0II3x2mKYsv4wp88jrisxOEjMAG6vOvnzE1LhKczQMElkRbk28H7gAwxsIPU8cBbwraqT39hW3SRpKkq9tZuz4G2O1wxzeg1UzH+L41bgtqqTPzvM+X3J0NCirCinEdd4P4S4TOvi6akrgdOBH1ed/OmWqidJPSkryhWAzZg/SGwBvHYhL7mXBXsmbu7HnglDwwTLinIpYB9iUHgHsFx66jHge8B3qk4+o6XqSVLfSh/kNmXBMRMbMbD7Z9c84myOG4Dru49VJ39swircAkPDBEi/iG8lrti4P7BKeuo54HzgR8BFThuSpMknK8pliWGiGyK2Ji5eNdxtjgcZFCLS4x97Ze0cQ8M4yYpyLWA/YlB4C7BMemoO8CtiUPhFP3ZvSVIvSMtnT09lu/S4OfNv5gXwNPOHiBuIK19OuQ+KhoYxkpZN3ZmBXeC2G/T0U8AFwM+AXzlOQZJ6U+qV2Ir4HtANEtsCyw45dQ5x1cvrUrmWOE5iUi+hbWh4ldLYhB2AXYC9iDu9Df6l+CMDQeHSqZgoJUmjlxXl4sS1drohYjvixoKrDTl1LnGQZTdEXAfcWHXy1nvPuwwNDaVuqB2JIWEX4t7yyww65WngEuBC4MKqk9891nWQJPWGtCbPBsTw0C3bM7CXUFd3wGU3RFwH3FB18qcmrrYDDA3DSHN7tyOGhB1S2XDIaU8ClxM3iboMuKrq5C+P5v8rSepvWVGuw4JBYoNhTr2L+YPEdVUnnzXe9evr0JDGIWxCHAk7uAw3IvZO4BoGgsItbjstSRpvaS+O7i2NbpAY+kEW4uJU3QDxlfGoS8+HhqwolyPOsd14UNkkPa7PgnNva2KCuwG4mhgUrmurK0iSpKHS0tnTGQgRrwdeR3pPqzr50Pe2MTHlQ0NWlNNe/8Btm5x71ievB9j+yB8c9/i0lddjICCst5CXzgPuI+6OdgtxFOvNxGkwToOUJE0paaXLbYHtq05+4nj8PyZtaEjbQa9GHBSyNvHNfwNi78D6g75eZdk5L3LbCQcBsPnHz+GFpf4yPnEusbvmriFlJlC5baokSc0tMZH/sxQEVgXWIO6LvhYDoWBoWZOBvRgW5nngzsXruQ8CewKsMOe5o15Yapm7icHgXqc6SpI0Nsa1pyEryh8T3/zXSGV1FlwpazgvA38CHhlUHgbuBx4Y9Phk1cnrybC4kyRJvW68exoOHvT1bOAh4NFB5ZGFlFnOTJAkaXIZ79DwZgYCwjO9smGHJEn9aNIOhBwRb09IkjTumowvkCRJMjRIkqRmeuP2RAMhhBkAdV1v2XZd+pVtMDnYDpOD7dA+22Dk7GmQJEmNGBokSVIjhgZJktSIoUGSJDViaJAkSY0YGiRJUiN9M+VSkiSNjj0NkiSpEUODJElqxNAgSZIaMTRIkqRGDA2SJKkRQ4MkSWqkJ0JDCGGPEMKMEMJdIYTTQgiLD3POT0IIj4YQ7hpy/NAQwuMhhBtS+dbE1bx3LKoNQgjTQwiXp3NuCSEcNei5JUIIZ6TXzggh7Drx/4LeMMp28FoYIw3aYVoI4ar0c54RQvivEMIS6TmvhzEwyjbwWliIKR8aQgiLAacB767remNgReDvhjn1FGCfhfxnzqvrenoqHxmnqvashm3wPPCBtAXtTsBHQwjT03OHAkun1x4CnB5CCBNS+R4yBu0AXguj1rAdXgD2qut6OrA1sPqgcw7F62FUxqANwGthWFM+NAA7Ag/VdX1r+v504MChJ9V1fQkwayIr1kcW2QZ1Xd9Z1/Ud6eungduADdLTBxIvcOq6vgl4HNhuAurda0bbDhobTdphXl3Xz6ZvlwCWBror7Xk9jN5o20AL0QuhYX3g/kHf38fI/wjuH0K4MYRwYQhhx7GrWt8YURuEEDYCdgAufzWv10KNth3Aa2EsNG6HEMKVwKPA08BZI329Fmq0bQBeC8PqhdAw2m67XwJZXdfbAl8BzgshLD/6avWVxm0QQlgZOB84uq7rbs+PXa9jY7Tt4LUwNhq3Q13XbwTWA1YF9hjp67VQo20Dr4WF6IXQcD/zJ8jXAA80fXFd14/Vdf1C+vrS9NpNx7SGva9RG4QQlgNK4NS6rn860tdrkUbVDl4LY2ZEv8+pi/znwP6v5vUa1qjawGth4XohNFwDrB9C2CJ9fzhwbtMXhxDWHfT1lkAG3DOWFewDi2yDEMKS6dhFdV2fNOT15wJHpPO2AdYArhvXGvemUbWD18KYadIOa6beHkIISwNvB2akp70eRm9UbeC1sHBTPjTUdT2XeIGdE0K4G3gW+H4I4YAQwmnd80IIJfAHIAshPBBCODY9dWSabnMDcCZwaF3XT0zsv2Jqa9gGBwN7A+8cNI3poPTcmcBLIU6HPRs4vHb71REbg3bwWhgDDdthXeC3IYSbiIHgVtLgR7weRm0M2sBrYSHcGluSJDUy5XsaJEnSxDA0SJKkRgwNkiSpEUODJElqxNAgSZIaMTRIkqRGDA2SJKkRQ4MkSWrE0CBJkhoxNEiSpEYMDZIkqRFDgyRJasTQIEmSGjE0SJKkRgwNkiSpEUODJElqxNAgSZIaMTRIkqRGDA2SJKkRQ4MkSWrE0CBJkhoxNEiSpEYMDZIkqRFDgyRJauT/AVbgglOL+2eqAAAAAElFTkSuQmCC"></button><div class="modal fade" id="plot_MRIQIwkguKCoBHApVAgYUDDs67ANYLGj" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0403040W0AAAAAA&amp;denomIds=4.3.4&amp;selectedTab=summary" target="_blank">Venlafaxine 37.5mg tablets : 1449</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0403040W0AAABAB&amp;denomIds=4.3.4&amp;selectedTab=summary" target="_blank">Venlafaxine 75mg tablets : 1880</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0403040W0AAADAD&amp;denomIds=4.3.4&amp;selectedTab=summary" target="_blank">Venlafaxine 75mg modified-release capsules : 2593</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0403040W0AAAEAE&amp;denomIds=4.3.4&amp;selectedTab=summary" target="_blank">Venlafaxine 150mg modified-release capsules : 2273</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0403040W0AAAJAJ&amp;denomIds=4.3.4&amp;selectedTab=summary" target="_blank">Venlafaxine 75mg modified-release tablets : 1269</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0403040W0AAAKAK&amp;denomIds=4.3.4&amp;selectedTab=summary" target="_blank">Venlafaxine 150mg modified-release tablets : 1446</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0403040W0AAALAL&amp;denomIds=4.3.4&amp;selectedTab=summary" target="_blank">Venlafaxine 225mg modified-release tablets : 723</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0403040W0AAAMAM&amp;denomIds=4.3.4&amp;selectedTab=summary" target="_blank">Venlafaxine 37.5mg modified-release tablets : 359</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0403040W0AAAQAQ&amp;denomIds=4.3.4&amp;selectedTab=summary" target="_blank">Venlafaxine 75mg/5ml oral solution : 8</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0403040W0AAASAS&amp;denomIds=4.3.4&amp;selectedTab=summary" target="_blank">Venlafaxine 37.5mg modified-release capsules : 618</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0403040W0AAATAT&amp;denomIds=4.3.4&amp;selectedTab=summary" target="_blank">Venlafaxine 225mg modified-release capsules : 238</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0403040W0AAAVAV&amp;denomIds=4.3.4&amp;selectedTab=summary" target="_blank">Venlafaxine 300mg modified-release tablets : 61</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0403040W0BBADAD&amp;denomIds=4.3.4&amp;selectedTab=summary" target="_blank">Efexor XL 75mg capsules : 54</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0403040W0BBAEAE&amp;denomIds=4.3.4&amp;selectedTab=summary" target="_blank">Efexor XL 150mg capsules : 48</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0403040W0BBAFAT&amp;denomIds=4.3.4&amp;selectedTab=summary" target="_blank">Efexor XL 225mg capsules : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0403040W0BGAAAD&amp;denomIds=4.3.4&amp;selectedTab=summary" target="_blank">Vensir XL 75mg capsules : 107</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0403040W0BGABAE&amp;denomIds=4.3.4&amp;selectedTab=summary" target="_blank">Vensir XL 150mg capsules : 99</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0403040W0BGACAT&amp;denomIds=4.3.4&amp;selectedTab=summary" target="_blank">Vensir XL 225mg capsules : 15</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0403040W0BIAAAJ&amp;denomIds=4.3.4&amp;selectedTab=summary" target="_blank">ViePax XL 75mg tablets : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0403040W0BIABAK&amp;denomIds=4.3.4&amp;selectedTab=summary" target="_blank">ViePax XL 150mg tablets : 6</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0403040W0BIADAB&amp;denomIds=4.3.4&amp;selectedTab=summary" target="_blank">ViePax 75mg tablets : 6</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0403040W0BLABAE&amp;denomIds=4.3.4&amp;selectedTab=summary" target="_blank">Venaxx XL 150mg capsules : 23</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0403040W0BNAAAJ&amp;denomIds=4.3.4&amp;selectedTab=summary" target="_blank">Venlalic XL 75mg tablets : 14</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0403040W0BNABAK&amp;denomIds=4.3.4&amp;selectedTab=summary" target="_blank">Venlalic XL 150mg tablets : 25</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0403040W0BNACAL&amp;denomIds=4.3.4&amp;selectedTab=summary" target="_blank">Venlalic XL 225mg tablets : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0403040W0BNADAM&amp;denomIds=4.3.4&amp;selectedTab=summary" target="_blank">Venlalic XL 37.5mg tablets : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0403040W0BRAAAD&amp;denomIds=4.3.4&amp;selectedTab=summary" target="_blank">Venlablue XL 75mg capsules : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0403040W0BRABAE&amp;denomIds=4.3.4&amp;selectedTab=summary" target="_blank">Venlablue XL 150mg capsules : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0403040W0BRACAS&amp;denomIds=4.3.4&amp;selectedTab=summary" target="_blank">Venlablue XL 37.5mg capsules : 6</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0403040W0BVAAAD&amp;denomIds=4.3.4&amp;selectedTab=summary" target="_blank">Depefex XL 75mg capsules : 74</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0403040W0BVABAE&amp;denomIds=4.3.4&amp;selectedTab=summary" target="_blank">Depefex XL 150mg capsules : 70</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0403040W0CCADAT&amp;denomIds=4.3.4&amp;selectedTab=summary" target="_blank">Vencarm XL 225mg capsules : 16</a></li></ul></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0607010C0&amp;denomIds=6.7.1&amp;selectedTab=summary">Cabergoline</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_4_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>241</td>
      <td>Bromocriptine and other dopaminergic drugs</td>
      <td>395</td>
      <td>0.61</td>
      <td>0.83</td>
      <td>0.10</td>
      <td>-2.24</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_EI1lCG5REKgEkAiIEi0REUCLtEwiGwO"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_EI1lCG5REKgEkAiIEi0REUCLtEwiGwO" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0607010C0AAAAAA&amp;denomIds=6.7.1&amp;selectedTab=summary" target="_blank">Cabergoline 500microgram tablets : 239</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=03N&amp;numIds=0607010C0BBAAAA&amp;denomIds=6.7.1&amp;selectedTab=summary" target="_blank">Dostinex 500microgram tablets : 2</a></li></ul></td></tr></tbody></table>
        </div>
      </div>
    </section>

    <script
      crossorigin="anonymous"
      integrity="sha512-pax4MlgXjHEPfCwcJLQhigY7+N8rt6bVvWLFyUMuxShv170X53TRzGPmPkZmGBhk+jikR8WBM4yl7A9WMHHqvg=="
      referrerpolicy="no-referrer"
      src="https://cdnjs.cloudflare.com/ajax/libs/bootstrap/5.1.3/js/bootstrap.bundle.min.js"
    ></script>
    <script>
      var tooltipTriggerList = [].slice.call(
        document.querySelectorAll('[data-bs-toggle="tooltip"]')
      );
      var tooltipList = tooltipTriggerList.map(function (tooltipTriggerEl) {
        return new bootstrap.Tooltip(tooltipTriggerEl);
      });
    </script>
</body>

</html>